UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 23, 2009 (September 23, 2009)
PHH CORPORATION
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
MARYLAND
(State or other jurisdiction
of incorporation)
|
|
1-7797
(Commission File Number)
|
|
52-0551284
(IRS Employer
Identification No.) |
3000 Leadenhall Road
Mt. Laurel, New Jersey 08054
(Address of principal executive offices, including zip code)
(856) 917-1744
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
|
|
|
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
In connection with PHH Corporation’s previously announced offering of $200 million aggregate
principal amount of convertible notes due 2014, PHH Corporation prepared a description of certain
risk factors related to its business and industry that are being presented to potential investors.
The risk factors are generally an update of the risk factors included in PHH Corporation’s Annual
Report on Form 10-K for the fiscal year ended December 31, 2008, which was filed with the
Securities and Exchange Commission (“SEC”) on March 2, 2009 and the risk factors included in PHH
Corporation’s Quarterly Report on Form 10-Q for the period ended March 30, 2009, which was filed
with the SEC on May 1, 2009. Additionally, PHH provided disclosure as to the impact of such risk
factors. The revised disclosure is filed herewith as Exhibit 99.1 and is incorporated herein by
reference.
|
|
|
| Item 9.01. |
|
Financial Statements and Exhibits. |
(d) Exhibits
2